Bio Special BioInvest
SanegeneBio Licenses RNAi Programme To Genentech In Global Deal Valued Up To USD 1.7 Billion
SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million up...
February 04, 2026 | News
GHIT Fund Commits JPY 1.39 Billion To Back Six R&D Programmes Across Malaria, Tuberculosis And Neglected Tropical Diseases
The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projec...
February 04, 2026 | News
AstraZeneca Commits $15 Billion Investment To Expand R&D And Manufacturing Footprint In China Through 2030
Landmark investment will expand AstraZeneca’s capabilities to discover, develop, and manufacture transformative new treatments in China In...
February 03, 2026 | News
DHL Group Strengthens Asia Pacific Healthcare Logistics With €10 Million Pharmaceutical Hub In Singapore
Strategic expansion positions Singapore as a strategic arm for healthcare logistics in the APAC region. DHL Group invests €10 million in a new phar...
February 02, 2026 | News
Corxel Pharmaceuticals Limited Secures Up To 287 Million Dollars In Series D1 Financing To Accelerate Global Cardiometabolic Pipeline
Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR ...
January 26, 2026 | News
HD And Pacific Prime Form Strategic Partnership To Expand AI Enabled Healthcare Access In Southeast Asia
Strategic partnership expands access to hybrid healthcare models through AI-driven navigation, connecting Pacific Prime clients to HDmall, HDcare, and Ji...
January 22, 2026 | News
Exciva Raises EUR 51 Million Series B To Advance Phase Two Alzheimer’s Agitation Trial
Series B financing will support Exciva's Phase 2 clinical trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's disease (AD) ...
January 21, 2026 | News
AstraZeneca Acquires Full Global Rights To CCAR031 From AbelZeta Pharma
AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietar...
January 20, 2026 | News
Bio Sourcing And Zerion Pharma Secure Eurostars Funding To Develop Oral Trastuzumab For HER2 Breast Cancer
Bio‑Sourcing and Zerion Pharma A/S announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody...
January 16, 2026 | News
Allele Joins Arpa H Programme To Bioprint Patient Specific Livers With Uc San Diego
Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based technology development and cell manufacturing company, announced its par...
January 15, 2026 | News
M&G Leads $50 Million Series C In bit.bio To Scale Human Cell Programming
M&G Investments (M&G) announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pionee...
January 12, 2026 | News
Ventaris Surgical Raises $30 Million Series A To Transform Kidney Stone Surgery
Ventaris Surgical, Inc., a San Carlos, CA-based medical device company developing a next-generation system for kidney stone treatment, announced the ...
January 12, 2026 | News
Ikarovec And VectorBuilder Advance Novel AAV Capsid To Enable Office Based Delivery Of IKAR 003 For Intermediate AMD
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to s...
January 07, 2026 | News
ScinoPharm Taiwan Becomes First In Country To Secure US FDA Approval For Multiple Sclerosis Injection
ScinoPharm Taiwan announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Gl...
January 06, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
